Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [698]
News [2436]
Articles [197]
Editorials [6]
Conferences [89]
elearning [31]
Future perspective of CDH1 mutation in gastric and breast cancers
Dr. Giovanni Corso - University of Milan, Italy, Meeting president
Future perspective of CDH1 mutation in gastric and breast cancers ( Dr. Giovanni Corso - University of Milan, Italy, Meeting president )
22 Jul 2020
Prophylactic gastrectomy in CDH1 mutation
Prof. Franco Roviello - University of Siena, Italy
Prophylactic gastrectomy in CDH1 mutation ( Prof. Franco Roviello - University of Siena, Italy )
22 Jul 2020
Pathology of diffuse gastric cancer with CDH1 mutation
Prof. Fàtima Carneiro - University of Porto, Portugal
Pathology of diffuse gastric cancer with CDH1 mutation ( Prof. Fàtima Carneiro - University of Porto, Portugal )
22 Jul 2020
CAPIRI versus irinotecan for the treatment of advanced gall bladder cancer...
Dr Anant Ramaswamy - Tata Memorial Hospital, Mumbai, India
CAPIRI versus irinotecan for the treatment of advanced gall bladder cancer patients progressing on first-line chemotherapy ( Dr Anant Ramaswamy - Tata Memorial Hospital, Mumbai, India )
13 Jul 2020
DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer
Prof Yu Sunakawa - St. Marianna University School of Medicine, Kawasaki, Japan
DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer ( Prof Yu Sunakawa - St. Marianna University School of Medicine, Kawasaki, Japan )
13 Jul 2020
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation...
Prof Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer ( Prof Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )
12 Jun 2020
Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based...
Prof Alberto Sobrero - Ospedale Policlinico San Martino, Genova, Italy
Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based therapy for patients with stage III colon cancer ( Prof Alberto Sobrero - Ospedale Policlinico San Martino, Genova, Italy )
12 Jun 2020
The PANDA study: Combining panitumumab with FOLFOX or 5FU in elderly patients...
Dr Sara Lonardi - Istituto Oncologico Veneto, Padua, Italy
The PANDA study: Combining panitumumab with FOLFOX or 5FU in elderly patients with RAS-BRAF WT metastatic colorectal cancer ( Dr Sara Lonardi - Istituto Oncologico Veneto, Padua, Italy )
11 Jun 2020
KEYNOTE-177 results: Pembrolizumab versus chemotherapy for patients with MSI-H...
Prof Thierry Andre - Sorbonne University and Saint-Antoine Hospital, Paris...
KEYNOTE-177 results: Pembrolizumab versus chemotherapy for patients with MSI-H/dMMR colorectal cancer ( Prof Thierry Andre - Sorbonne University and Saint-Antoine Hospital, Paris, France )
5 Jun 2020
Highlights from ASCO 2020
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Highlights from ASCO 2020 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
5 Jun 2020
An oncologist's experience of managing breast cancer during the COVID-19...
Prof Alessandra Gennari - University Hospital of Novara, Piedmont, Italy
An oncologist's experience of managing breast cancer during the COVID-19 outbreak ( Prof Alessandra Gennari - University Hospital of Novara, Piedmont, Italy )
28 Apr 2020
The potential of KRAS inhibitors for non-small-cell lung cancer
Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany
The potential of KRAS inhibitors for non-small-cell lung cancer ( Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany )
22 Apr 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation